AFATINIB-A COMPREHENSIVE REVIEW OF ANALYTICAL METHODS DEVELOPED IN PHARMACEUTICALS AND BIOLOGICAL MATRICES

Afatinib is a selective irreversible ErbB family blocker that can be taken orally and has demonstrated broad-range effectiveness in preclinical studies against Epidermal Growth Factor Receptor (EGFR) mutations. The inhibition of ErbB receptors by afatinib may stop the development and spread of tumou...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of applied pharmaceutics pp. 23 - 28
Main Authors KUMAR, HEMANTH, KUMAR, LALIT, VERMA, RUCHI
Format Journal Article
LanguageEnglish
Published 07.07.2024
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first